The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Anderson, C. M.
* Articles by Teicher, M. H.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Anderson, C. M.
* Articles by Teicher, M. H.
Related Collections
* Neurophysiology
* Child/Adolescent Psychiatry
* Gender
* fMR
* Attention Deficit Hyperactivity Disorder
* Other Somatic Therapy
Am J Psychiatry 159:1322-1328, August 2002
© 2002 American Psychiatric Association


Article

Effects of Methylphenidate on Functional Magnetic Resonance Relaxometry of the Cerebellar Vermis in Boys With ADHD

Carl M. Anderson, Ph.D., Ann Polcari, R.N., Ph.D., Steven B. Lowen, Ph.D., Perry F. Renshaw, M.D., Ph.D., and Martin H. Teicher, M.D., Ph.D.

OBJECTIVE: The authors used functional magnetic resonance imaging (fMRI) to test the effects of methylphenidate on steady-state blood volume in the midline vermis of the cerebellum in boys with attention deficit hyperactivity disorder (ADHD). This region was selected as it has been observed to be significantly smaller in children with ADHD. Also, in preclinical studies, the vermis has been shown to modulate forebrain dopamine systems, to influence locomotor activity, and to contain a significant density of dopamine transporters. METHOD: T2 relaxometry was used to indirectly assess blood volume in the cerebellum (hemispheres and midline vermis) of 10 boys with ADHD who were administered placebo or one of three different doses of methylphenidate continuously for 1 week. T2 relaxation time values are inversely proportional to local cerebral blood volume. After each week of treatment, and within 1–3 hours of the boys’ afternoon dose, testing for drug efficacy was performed by using objective measures of activity. RESULTS: Moderate and high doses of methylphenidate increased T2 relaxation time in a rate-dependent manner—increasing T2 relaxation time in the most active children with ADHD and reducing T2 relaxation time in subjects with ADHD who were not objectively hyperactive. CONCLUSIONS: This preliminary study supports a role for the vermis in ADHD and suggests that further research is needed to clarify the relationship between vermal size, vermal blood flow, stimulant response, and the developmental pathophysiology of ADHD.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
G. Bush, T. J. Spencer, J. Holmes, L. M. Shin, E. M. Valera, L. J. Seidman, N. Makris, C. Surman, M. Aleardi, E. Mick, et al.
Functional Magnetic Resonance Imaging of Methylphenidate and Placebo in Attention-Deficit/Hyperactivity Disorder During the Multi-Source Interference Task
Arch Gen Psychiatry, January 1, 2008; 65(1): 102 - 114.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
P. Weber, J. Lutschg, and H. Fahnenstich
Methylphenidate-Induced Changes in Cerebral Hemodynamics Measured by Functional Near-Infrared Spectroscopy
J Child Neurol, July 1, 2007; 22(7): 812 - 817.
[Abstract] [PDF]


Home page
BrainHome page
L. Chang, R. Yakupov, C. Cloak, and T. Ernst
Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation
Brain, May 1, 2006; 129(5): 1096 - 1112.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. Wang, S. Vijayraghavan, and P. S. Goldman-Rakic
Selective D2 Receptor Actions on the Functional Circuitry of Working Memory
Science, February 6, 2004; 303(5659): 853 - 856.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org